Gaucher disease is an autosomal recessive disorder characterized by an accumulation of the sphingoglycolipid glucocerebroside. It is due to a deficiency of the enzyme glucocerebrosidase (1, 2) . The most common form of this disorder, designated type I, is prevalent in those of Eastern European Jewish ethnic origin. The gene frequency in this group may be as high as 0.02-0.04 (3, 4) . Type I disease also occurs sporadically in non-Jewish populations. More severe forms of the disease, designated types II and III, are associated with central nervous system involvement and do not seem to have any predilection for those of Jewish ancestry. It has been proposed (3) that the existence of Gaucher disease at polymorphic frequencies in the Eastern European Jewish population might be due to a single gene mutation in "an extended kindred" (3), as it were. However, we have previously suggested, on the basis of the severity of the defect as found in different family groupings (5, 6) and of immunologic examination of the residual enzyme (7) , that even within this population Gaucher disease was genetically heterogeneous.
We have now succeeded in cloning human glucocerebrosidase cDNA. Using a large cloned fragment of this gene as a probe, we have discovered a restriction polymorphism that clearly establishes that even within the Eastern European Jewish population, gene defects for Gaucher disease have arisen independently more than once.
MATERIALS AND METHODS
The cloning of glucocerebrosidase cDNA in X phage gtll and its complete sequence will be described in detail in another paper (8) . Sequencing of the DNA probe was accomplished by the method of Maxam and Gilbert (9) . The probe used in the present studies was a 1039-base-pair (bp) cDNA fragment (our clone G5A-1Y). It was cut from a pBR322 plasmid and purified by preparative agarose gel electrophoresis. A radioactive probe was prepared by reverse transcribing the denatured DNA in the presence of the following: random calf thymus primers (1 mg/ml), 50 1 Ci = 37 GBq). The probe was isolated by Sephadex G-50 filtration.
Restriction endonucleases were obtained from the commercial sources listed in Table 1 . DNA was isolated from peripheral blood leukocytes or from cultured skin fibroblasts by standard techniques (10) . Ten micrograms of the purified DNA was incubated with 150-200 units of restriction endonuclease for 2.5 hr at 370C. After electrophoresis in 0.8% agarose for 16 hr at 1.7 V/cm, the DNA was transferred to nitrocellulose filters, developed by addition of -1 ,Ci of probe per 100 cm2 of filter, and visualized using XAR x-ray film (11) . A HindIII digest of X DNA provided molecular weight markers.
Whenever variation in the restriction pattern was seen, digestion of an additional sample of DNA was carried out with twice the amount of enzyme, and samples were taken at time intervals to make certain that DNA digestion by the restriction endonuclease had been complete.
RESULTS
The DNA sequence of the probe used in this study is depicted in Fig. 1 . It represents the 5' end of the glucocerebrosidase cDNA.
The results of restriction endonuclease mapping of genomic DNA from unrelated individuals with 20 different restriction enzymes is shown in Table 1 . Variability in the pattern was observed only with two restriction endonucleases-namely, Pvu II and Kpn I. Further studies using these two restriction endonucleases were therefore performed. The restriction patterns produced with these enzymes in Gaucher disease patients and in normal subjects are presented in Figs. 2 and 3.
In the case of Pvu II, the examined subjects could be fairly evenly divided into those whose digested DNA contained a 1.1-kilobase (kb) fragment and those whose DNA did not. The gene that produced the 1.1-kb fragment was designated Pv1.1+ and the gene that lacked the fragment was designated Pvl.l-. Since even one Pv1.1+ gene would produce a 1.1-kb fragment, agenotype of Pvl.l-/Pvl.1-was assigned to those who lacked the 1.1-kb fragment and a genotype of Pvl.1+/Pvl.l-was assigned to those in whom the fragment was present. The validity of this interpretation was confirmed by the discovery of a family in which both parents had the Abbreviations: bp, base pair(s); kb, kilobase(s).
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DNA from normal controls and from patients with Ga disease and their family members was screened for restr polymorphisms with 20 different restriction endonuclh Two genetic variants were found, a common variant wit II and a less common one with Kpn I.
The appearance of a new 1. The present studies unequivocally indicate that selection is the cause of the high frequency of the type I Gaucher disease gene in the Jewish population. In patients with this recessively inherited disorder, both alleles at the glucocerebrosidase locus have a Gaucher disease mutation. Since five Jewish patients with Gaucher disease were heterozygous for the Pvl.1 polymorphism, Gaucher disease genes are commonly linked to both Pv1.1+ and Pvl.1-genes; the fact that the Gaucher mutation is found in association with both alleles ofthe ancient Pvu II polymorphism indicates that it has arisen more than once in the Jewish population. To be repeatedly amplified in one population, mutations producing glucocerebrosidase deficiency must have provided a selective advantage.
Not surprisingly, further heterogeneity was encountered in non-Jewish Gaucher disease patients. Here, variability at a Kpn I site was discovered in a non-Jewish child with Gaucher disease. Thus, the Gaucher disease gene that arose in conjunction with the Kpn I site presumably was another independent genetic event. In this case, however, the relative rarity of the Kpn I mutation makes it remotely possible that the Kpn I mutation was a recent genetic event engrafted upon a preexisting Gaucher disease mutation. It is even possible that one of the Gaucher disease mutations in this patient creates or abolishes a Kpn I site.
Since we do not yet have knowledge of the precise base-pair substitution(s) of the Pv1.1+ and the Pvl.1-linked Gaucher disease mutations, we are not certain whether these independently arising mutational events were identical. In the case of the sickle cell mutation, an identical change in the base-pair sequence appears to have arisen independently on several occasions in different populations (13) . However, the sickling phenomenon is subject to a great many molecular constraints, while enzyme deficiencies may be produced by 5444 Genetics: Sorge et al.
a myriad of base-pair changes. We consider it unlikely that the mutation found in the various Gaucher disease mutations will be the same. Moreover, studies of cross-reacting immunologic materials in Gaucher disease (7) and family studies (6) have already suggested that Gaucher disease, even within the Jewish population, is heterogeneous. The cloned glucocerebrosidase gene may, in the future, prove to be useful in developing gene replacement therapy for this serious genetic disease (14) . At present, it has enabled us to gain insight into the population genetics of this disorder. In addition, the existence of restriction polymorphisms will make the probe a useful tool, in selected cases, for heterozygote detection and prenatal diagnosis.
